TP53 and cancer: By inactivating genes such as TP53 (commonly mutated in many cancers), researchers can examine the consequences of their loss and better understand the mechanisms by which these mutations contribute to cancer development and progression.17, 18Gene editing via CRISPR–Cas9 can also be utilized to investigate the role of oncogenes in cancer.